- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
BioMarin Pharmaceutical Inc+ Add to Watchlist
BMRN:US116.9700 USD 3.3100 2.75%
As of 20:10:00 ET on 04/27/2015.
Company Profile for BioMarin Pharmaceutical Inc (BMRN)
BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.
BioMarin Pharmaceutical Inc
Key Executives for BioMarin Pharmaceutical Inc (BMRN)
|Jean-Jacques BienaimeChief Executive Officer||Daniel K Spiegelman "Dan"Exec VP/CFO|
|Jeffrey R AjerExec VP/Chief Commercial Ofcr||Henry J FuchsExec VP/Chief Medical Officer|
|Robert A BaffiExec VP:Technical Operations||G Eric DavisSenior VP/Secretary/Gen Cnsl|
|Richard J RanieriSenior VP:Human Resources||Brian R MuellerVP/Chief Acctg Ofcr/Controller|
|Traci McCartyDirector:Investor Relations|